AU622101B2 - Oral administration capsule with a nicotine-containing fluid medium - Google Patents

Oral administration capsule with a nicotine-containing fluid medium Download PDF

Info

Publication number
AU622101B2
AU622101B2 AU81712/87A AU8171287A AU622101B2 AU 622101 B2 AU622101 B2 AU 622101B2 AU 81712/87 A AU81712/87 A AU 81712/87A AU 8171287 A AU8171287 A AU 8171287A AU 622101 B2 AU622101 B2 AU 622101B2
Authority
AU
Australia
Prior art keywords
nicotine
capsule
document
fluid medium
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU81712/87A
Other languages
English (en)
Other versions
AU8171287A (en
Inventor
Franz Adlkofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FORSCHUNGSGESELLSCHAFT RAUCHEN und GESUNDHEIT MBH
Original Assignee
FORSCHUNGSGESELLSCHAFT RAUCHEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FORSCHUNGSGESELLSCHAFT RAUCHEN filed Critical FORSCHUNGSGESELLSCHAFT RAUCHEN
Publication of AU8171287A publication Critical patent/AU8171287A/en
Application granted granted Critical
Publication of AU622101B2 publication Critical patent/AU622101B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU81712/87A 1986-11-18 1987-11-06 Oral administration capsule with a nicotine-containing fluid medium Ceased AU622101B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863639418 DE3639418A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
DE3639418 1986-11-18

Publications (2)

Publication Number Publication Date
AU8171287A AU8171287A (en) 1988-06-16
AU622101B2 true AU622101B2 (en) 1992-04-02

Family

ID=6314221

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81712/87A Ceased AU622101B2 (en) 1986-11-18 1987-11-06 Oral administration capsule with a nicotine-containing fluid medium

Country Status (9)

Country Link
EP (1) EP0324794B1 (enrdf_load_stackoverflow)
JP (1) JP2602043B2 (enrdf_load_stackoverflow)
CN (1) CN87107852A (enrdf_load_stackoverflow)
AT (1) ATE72114T1 (enrdf_load_stackoverflow)
AU (1) AU622101B2 (enrdf_load_stackoverflow)
BR (1) BR8707879A (enrdf_load_stackoverflow)
DE (3) DE3645036A1 (enrdf_load_stackoverflow)
DK (1) DK173353B1 (enrdf_load_stackoverflow)
WO (1) WO1988003803A1 (enrdf_load_stackoverflow)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4440563A1 (de) * 1994-11-12 1996-05-15 Herzog Sen Rolf Verfahren und Mittel zum Genuß von Tabak - Nikotin unter Vermeidung schädlicher Verbrennungs - Derivate
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5846983A (en) * 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6211194B1 (en) 1998-04-30 2001-04-03 Duke University Solution containing nicotine
US6268386B1 (en) * 1998-06-25 2001-07-31 Marshall Anlauf Thompson Nicotine beverage
GB2338896B (en) * 1998-07-02 2003-05-21 Reckitt & Colmann Prod Ltd Chewable Capsules
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
DK1202736T3 (da) 1999-07-28 2008-12-15 Univ Leland Stanford Junior Nikotin i terapeutisk angiogenese og vasculogenese
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
ES2708551T3 (es) 2002-12-20 2019-04-10 Niconovum Ab Material particulado que contiene nicotina con una celulosa cristalina
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
WO2005007068A1 (en) * 2003-07-22 2005-01-27 The Kiwigel Company Limited Nicotine packaging system
NO20042835D0 (no) * 2004-07-05 2004-07-05 Nils-Erik Skeide Innkapslet tobakksroyk
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
WO2007104573A2 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US7718677B2 (en) * 2007-04-02 2010-05-18 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
CN101249130B (zh) * 2008-04-11 2011-06-15 桂林商源植物制品有限公司 一种戒烟并缓解戒烟综合症的药用或保健组合物
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
WO2016145373A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
US10568852B2 (en) 2015-05-22 2020-02-25 Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Combination compositions and their use in methods for treating obesity and obesity-related disorders
CN105341990A (zh) * 2015-12-16 2016-02-24 浙江中烟工业有限责任公司 一种提升电子烟生理满足感的电子烟烟液
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
EP3880175A4 (en) 2018-11-16 2022-08-17 Morningside Venture Investments Limited TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5173585A (en) * 1984-12-25 1986-07-03 Tyroler, J. Flavour capsule
AU5427586A (en) * 1985-03-05 1986-10-16 Ciba-Geigy Ag Device and methods for treating memory impairment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (enrdf_load_stackoverflow) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US3870794A (en) * 1974-02-20 1975-03-11 Foundation For Behavioral Rese Treatment of certain emotional disorders with nicotine compounds
GB1528391A (en) * 1976-01-05 1978-10-11 Gildemeister V Aerosol compositions
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
BE899037A (fr) * 1984-02-29 1984-06-18 Trenker Ady Composition a sucer permettant de cesser de fumer
DE3438284A1 (de) * 1984-10-16 1985-03-07 Hans-Harald von 2400 Lübeck Tilly Nikotinhaltiges depotpflaster

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5173585A (en) * 1984-12-25 1986-07-03 Tyroler, J. Flavour capsule
AU5427586A (en) * 1985-03-05 1986-10-16 Ciba-Geigy Ag Device and methods for treating memory impairment

Also Published As

Publication number Publication date
DE3639418C2 (enrdf_load_stackoverflow) 1989-08-03
AU8171287A (en) 1988-06-16
DK173353B1 (da) 2000-08-07
CN87107852A (zh) 1988-06-22
DK385888A (da) 1988-07-08
DE3776574D1 (de) 1992-03-12
BR8707879A (pt) 1989-10-03
JP2602043B2 (ja) 1997-04-23
EP0324794B1 (de) 1992-01-29
DE3639418A1 (de) 1988-06-09
JPH02501304A (ja) 1990-05-10
ATE72114T1 (de) 1992-02-15
DE3645036A1 (de) 1989-01-05
DK385888D0 (da) 1988-07-08
WO1988003803A1 (en) 1988-06-02
EP0324794A1 (de) 1989-07-26

Similar Documents

Publication Publication Date Title
AU622101B2 (en) Oral administration capsule with a nicotine-containing fluid medium
US5298257A (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
JP5845194B2 (ja) ニコチン含有ソフトゼラチントローチ
Gourlay et al. Antismoking products
MX2011003984A (es) Forma de dosis intraoral de multiples porciones y uso de esta.
US6045825A (en) Plantago major and Piper methysticum compound for use in treating a tobacco or nicotine habit
US6645470B1 (en) Treatment and system for nicotine withdrawal
Wongwiwatthananukit et al. Efficacy of Vernonia cinerea for smoking cessation
RU2445971C2 (ru) Водный экстракт листьев табака и его применение при лечении зависимости
US5716635A (en) Plantago major transdermal patch for use in treating a tobacco or nicotine habit
US9226944B2 (en) Herbal preparation for sleep apnea relief
WO2018169387A1 (en) Tobacco- and smoke-less products consumable by humans as epicurean or medical products and method of treating smoking addiction
US5130132A (en) Composition and method for treating nicotine dependency
CN104548020B (zh) 一种药物组合物在制备治疗老年痴呆症药物中的用途
EP0955053A1 (en) A plantago major and hypericum perforatum compound for use in treating a tobacco or nicotine habit
JPH09507053A (ja) ニコチン禁断症状の治療のためのロベリンの使用
CN1050052C (zh) 戒烟穴贴膏
Potter A Compend of Materia Medica, Therapeutics and Prescription Writing, with Especial Reference to the Physiological Actions of Drugs
JPS6296418A (ja) 薬用チユ−インガム
Ostrowski et al. Pharmacologic management of patients using smoking cessation aids
Hassan et al. Effect of illicit drugs on dental health-A review
IE57786B1 (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
Dixon THE TWELFTH NORMAN KERR MEMORIAL LECTURE: 1927.* THE TOBACCO HABIT
Pekgor et al. 1The Department of Family Medicine, 2The Department of General Surgery and Director of Family Medicine Clinic, Konya Training and Research Hospital, University of Health Sciences, Konya, Turkey
CN102885956A (zh) 一种助眠中药组合物及其制备方法

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired